Aortic aneurysm associated with decreased incidence of atherosclerosis

September 13, 2005

New Haven, Conn.-Oddly enough, having an aneurysm in the ascending aorta is significantly associated with decreased incidence of atherosclerosis, according to a study by Yale School of Medicine researchers published this month in Chest.

An aortic aneurysm is a widening of the major artery leading from the heart that may rupture, causing hemorrhage, or may split into layers, jeopardizing blood flow to internal organs. When split into layers it is called "aortic dissection."

"This is a silver lining in the cloud of aneurysm disease," said John Elefteriades, M.D., section chief of cardiothoracic surgery in the Department of Surgery and senior author of the study.

He said the study was prompted by clinical observations that patients with aortic aneurysm and dissection-men and women, young and elderly-had a noteworthy absence of atherosclerosis. Most patients, Elefteriades said, begin showing the earliest signs of atherosclerosis in their 20s. "Surprisingly, the arteries of the patients with ascending aortic aneurysm looked like a baby's or a young child's," he said.

This study included 64 patients between 36 and 82 years of age with aortic aneurysm or dissection. The control group consisted of 86 trauma patients who had undergone computerized tomography of the chest. The lower prevalence of calcification in patients with ascending aortic aneurysm and dissection was independent of the major risk factors for heart disease-age, gender, high cholesterol, hypertension, diabetes and smoking history. In fact, the aneurysm patients appeared to be significantly protected despite a higher cholesterol level.

In earlier studies Elefteriades and his colleagues demonstrated the heritable nature of ascending aortic aneurysm and dissection. He said it is conceivable that the mutations inherent in aortic aneurysm also play a role in the atherosclerotic process.

"If patients with certain heritable aortic pathologies exhibit decreased systemic atherosclerosis, this finding would be important by virtue of providing new insights into the pathophysiology of the most common cause of death in the western world, heart and blood vessel disease due to atherosclerosis," he said.
-end-
Chest: (September 2005)

Yale University

Related Atherosclerosis Articles from Brightsurf:

How hormone therapy slows progression of atherosclerosis
As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis.

T cells can shift from helping to harming in atherosclerosis
At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place.

New nanoparticle drug combination for atherosclerosis
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Atherosclerosis -- How a microRNA protects vascular integrity
Ludwig-Maximilian-Universitaet (LMU) in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.

Atherosclerosis progresses rapidly in healthy people from the age of 40
A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.

Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing
By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs -- surmounting a major obstacle in nanomedicine.

Bladder drug linked to atherosclerosis in mice
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences (PNAS).

A new therapeutic target for blocking early atherosclerosis in progeria
Researchers at the Centro Nacional de Investigaciones Cardiovasculares and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome.

Protective mechanism against atherosclerosis discovered
Immune cells promoting inflammation play a crucial role in the development of atherosclerosis.

Atherosclerosis: Stopped on time
For the first time, LMU researchers are pointing out the influence of the internal clock on atherosclerosis.

Read More: Atherosclerosis News and Atherosclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.